Targeted Mutation Analysis (More than 2 Mutations) in UAE

Executive Summary & Core Metrics

This targeted mutation analysis detects specific pathogenic variants with 99.9% diagnostic sensitivity. Processed in an ISO 9001:2015 accredited laboratory using Sanger sequencing, the test includes a free telephonic result interpretation session and direct insurance billing verification via WhatsApp at +971 54 548 8731. Home collection is available daily from 8 AM to 11 PM through VIP Mobile Phlebotomy with temperature-controlled cold-chain transport.

Test Overview & Methodology

Targeted Mutation Analysis examines specific DNA changes in genes that cause hereditary syndromes such as BRCA-related cancers, thalassemia, or other inherited disorders. The gold-standard Sanger sequencing method ensures ultimate accuracy, aiding personalized treatment plans and informed clinical decisions.

Feature	Our Test	Closest Alternative (NGS Panel)
Method	Sanger Sequencing (Gold Standard)	Next-Generation Sequencing
Diagnostic Sensitivity	99.9%	98-99%
Turnaround Time	10-15 business days	14-21 business days
Price (AED)	2,600	~3,500

Physician Insight & Safety Protocols

"As a genetic counselor, I emphasize that this test provides precise molecular data to guide preventive strategies and treatment plans. However, genetic results must always be interpreted alongside the full clinical history and family pedigree. I strongly recommend a consultation with a medical geneticist to contextualize these findings." — Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403

Advisory: Medication Continuity

Always continue prescribed medications unless explicitly instructed by your treating physician. This test is diagnostic and does not replace ongoing medical management. Discuss any concerns about your medication regimen with your healthcare provider prior to sample collection.

Safety Exclusion Criteria & Emergency Information

A valid UAE physician’s prescription is required (exceptions apply for presurgical clearance, pregnancy-related screening, or travel abroad – prescription not required per DHA guidelines).
Minors under 18 years must have parental or guardian consent in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
Patients with active bleeding disorders or on anticoagulant therapy require specialized collection – please notify the nurse at booking.
ER Red Flags: Seek immediate medical attention if you experience severe pain, uncontrolled bleeding, swelling, or signs of infection (fever, redness) at the draw site. This test does not substitute for emergency diagnostics; always follow your physician’s advice for acute symptoms.

Patient FAQ & Clinical Guidance

1. What does this test specifically detect?

This analysis pinpoints known pathogenic mutations in genes associated with hereditary cancer syndromes (e.g., BRCA1/2), hemoglobinopathies (e.g., thalassemia), and other monogenic disorders. Using Sanger sequencing, it delivers a definitive result for pre-specified variants, enabling targeted surveillance and personalized intervention.

2. Do I need a doctor’s prescription?

UAE regulations require a valid prescription from a licensed physician for all genetic tests to ensure appropriate clinical oversight. Exceptions are made for presurgical clearance, pregnancy-related screening, and travel abroad where medical documentation is needed. Contact us via WhatsApp at +971 54 548 8731 to verify your specific eligibility.

3. How quickly will I receive my results?

Your report will be delivered within 10–15 business days directly to your referring physician. A complimentary telephonic interpretation session is included to explain the clinical implications and answer any questions you or your doctor may have about the findings.

UAE Regulatory & Data Privacy Adherence

All procedures comply with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. Your genetic data is encrypted, access-restricted, and processed solely for diagnostic purposes under DHA oversight.

Clinical & Logistical Metadata

Test Name	Targeted Mutation Analysis (More than 2 Mutations)
Price (AED)	2,600
Turnaround Time	10–15 business days
Sample Type / Matrix	Peripheral Blood (Whole Blood)
Methodology Used	Sanger Sequencing
ICD-10-CM Code	Z13.89
LOINC Code	55233-1
DHA Facility License & Laboratory Address	DHA Facility License: 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE \| Corporate Lab: DNA Labs UAE